Logo image of CERO

CERO THERAPEUTICS HOLDINGS I (CERO) Stock Earnings & Estimates

USA - NASDAQ:CERO - US71902K4022 - Common Stock

2.6 USD
-0.25 (-8.61%)
Last: 10/15/2025, 8:19:08 PM
2.5999 USD
0 (0%)
After Hours: 10/15/2025, 8:19:08 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
CERO revenue by date.CERO revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
CERO ebitda by date.CERO ebitda by date.
N/AN/AN/A-15.76MN/AN/AN/AN/AN/A
EBIT
YoY % growth
CERO ebit by date.CERO ebit by date.
-332K-2.905M
-775.12%		-2.933M
-0.95%		-16.198M
-452.27%		N/A
-12.42%		N/A
-20.22%		N/A
-64.23%		N/AN/A
Operating Margin
CERO operating margin by date.CERO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CERO eps by date.CERO eps by date.
N/AN/AN/AN/AN/AN/A
38.38%		N/A
1.01%		N/A
-17.88%		N/A
1.89%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-9.24-4.74
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-4.585M
-4.16%		-4.868M
-132.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 -28.80 -121.5892.7876.31%
CERO Yearly EPS VS EstimatesCERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -496.05% 0% 75.79%
RevenueN/A N/A N/A N/A